Infant Bacterial Therapeutics AB (publ) Cash Flow Quality Index
Infant Bacterial Therapeutics AB (publ) cash flow quality index. Infant Bacterial Therapeutics AB (publ) (IBT-B) has a Cash Flow Quality Index of -17.11x as of June 2022. Operating cash flow of Skr-30.09 Million is below net income of Skr1.76 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Infant Bacterial Therapeutics AB (publ) to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Infant Bacterial Therapeutics AB (publ) Cash Flow Quality Index by Year (None–None)
Infant Bacterial Therapeutics AB (publ) cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Infant Bacterial Therapeutics AB (publ). For the full cash flow conversion analysis, see Infant Bacterial Therapeutics AB (publ) cash flow conversion.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|